Evidence map›Paper›PMID 30039479›Full record

GuidelineClinical and experimental nephrology2018

The Japanese clinical practice guideline for acute kidney injury 2016.

Kent Doi, Osamu Nishida, Takashi Shigematsu, Tomohito Sadahiro, Noritomo Itami, Kunitoshi Iseki, Yukio Yuzawa, Hirokazu Okada, Daisuke Koya, Hideyasu Kiyomoto and 14 more

Abstract readPractice GuidelineReview
In one paragraph

Guideline in Clinical and experimental nephrology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Article
  4. Review
  5. Review
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Review
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Kent DoiDepartment of Acute Medicine, The University of Tokyo, Tokyo, Japan.
Osamu NishidaDepartment of Anesthesiology and Critical Care Medicine, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Takashi ShigematsuDepartment of Nephrology, Wakayama Medical University, Wakayama, Japan.
Tomohito SadahiroDepartment of Emergency and Critical Care Medicine, Tokyo Women's Medical University Yachiyo Medical Center, Chiba, Japan.
Noritomo ItamiDepartment of Surgery, Kidney Center, Nikko Memorial Hospital, Hokkaido, Japan.
Kunitoshi IsekiClinical Research Support Center, Tomishiro Central Hospital, Okinawa, Japan.
Yukio YuzawaDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Hirokazu OkadaDepartment of Nephrology and General Internal Medicine, Saitama Medical University, Saitama, Japan.
Daisuke KoyaDivision of Anticipatory Molecular Food Science and Technology, Department of Diabetology and Endocrinology, Kanazawa Medical University, Kanawaza, Ishikawa, Japan.
Hideyasu KiyomotoDepartment of Community Medical Supports, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Yugo ShibagakiDivision of Nephrology and Hypertension, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Kenichi MatsudaDepartment of Emergency and Critical Care Medicine, University of Yamanashi School of Medicine, Yamanashi, Japan.
Akihiko KatoBlood Purification Unit, Hamamatsu University Hospital, Hamamatsu, Japan.
Terumasa HayashiDepartment of Kidney Disease and Hypertension, Osaka General Medical Center, Osaka, Japan.
Tomonari OgawaNephrology and Blood Purification, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Tatsuo TsukamotoDepartment of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Eisei NoiriDepartment of Nephrology and Endocrinology, The University of Tokyo, Tokyo, Japan.
Shigeo NegiDepartment of Nephrology, Wakayama Medical University, Wakayama, Japan.
Koichi KameiDivision of Nephrology and Rheumatology, National Center for Child Health and Development, Tokyo, Japan.
Hirotsugu KitayamaDepartment of Nephrology, Shizuoka Children's Hospital, Shizuoka, Japan.
Naoki KashiharaDepartment of Nephrology and Hypertension, Kawasaki Medical School, Okayama, Japan.
Toshiki MoriyamaHealth Care Division, Health and Counseling Center, Osaka University, Osaka, Japan.
Yoshio TeradaDepartment of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku, Kochi, 783-8505, Japan. terada@kochi-u.ac.jp.
Japanese Clinical Practice Guideline for Acute Kidney Injury 2016 Committee

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute kidney injury (AKI) is a syndrome which has a broad range of etiologic factors depending on different clinical settings. Because AKI has significant impacts on prognosis in any clinical settings, early detection and intervention is necessary to improve the outcomes of AKI patients. This clinical guideline for AKI was developed by a multidisciplinary approach with nephrology, intensive care medicine, blood purification, and pediatrics. Of note, clinical practice for AKI management which was widely performed in Japan was also evaluated with comprehensive literature search.

Indexed as

Renal DialysisAcute Kidney InjuryHumansJapanNephrologyObservational Studies as TopicRandomized Controlled Trials as TopicRenal Replacement TherapyAcute kidney injuryAtrial natriuretic peptideBiomarkerBlood purificationLong-term follow-upNafamostat mesilate

Identifiers

PMID30039479
PMCPMC6154171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.